LungLife AI, Inc.

As of December 31, 2023, LungLife AI, Inc. has 25.49M shares outstanding.

As of December 31, 2023, LungLife AI, Inc. maintains a current ratio of 2.28, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.37, indicating elevated leverage, while an interest coverage ratio of -140.93 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2023. Return on assets (ROA) is negative at -44.11, reflecting losses generated across the asset base.

Over the twelve months ended December 31, 2023, LungLife AI, Inc. posted a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -12,560.87 and net profit margin of -11,767.39 provide insight into operational efficiency.

As of December 31, 2023, LungLife AI, Inc. has an Altman Z-Score of -36.71, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.